Cite
HARVARD Citation
Pavlidis, P. et al. (2018). Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease. Alimentary pharmacology & therapeutics. 47 (10), pp. 1422-1423. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pavlidis, P. et al. (2018). Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease. Alimentary pharmacology & therapeutics. 47 (10), pp. 1422-1423. [Online].